Instagram set off a social media firestorm by removing a photo deemed offensive; it was of a young boy with a congenital syndrome, replete with facial deformities. And, it wasn't the first time this occured.

A new study in JAMA Surgery reports that a crucial decision – whether a breast cancer patient should undergo a double mastectomy when only one breast is affected – is heavily influenced by her surgeon's recommendation.

Most Americans are rightly squeamish about forcing anyone to do anything against their will. But allowing homeless people to do whatever they want is no longer a viable solution. When a community fails to practice proper hygiene and sanitation, it becomes a ticking time bomb for infectious disease.

Due to the opaque nature of the pharmaceutical industry’s disclosures, a study published in JAMA Internal Medicine sought to quantify a standard amount companies spent on the research and development of cancer drugs. Do these R&D costs justify such high prices and revenues?

There is ongoing discussion in the medical community and among politicians about when and whether terminally ill patients can receive access to medicines not approved by regulators. With the support of the “right to try” movement, 37 states—and recently, the U.S. Senate—have passed laws aimed at providing easier access to experimental treatments that have undergone only the most rudimentary human testing.

We sometimes think that if you give people true, scientific information they will listen. But then that theory is blown away by a reality check, such as with the case of an Australian man who continued to take supplements derived from apricot kernels – that doctors told him was giving him chronic cyanide poisoning.

The Biohacker Summit, the largest event of its kind in Europe which promotes DIY bio- and citizen-science, dis-invited David Avocado Wolfe from speaking. In doing so, officials there not only secured a win for the pro-science community, they also rejected the wacky pseudoscience that Wolfe, and his ilk, promotes. 

Medicare doesn't dispute how much pharmaceutical companies charge for their drugs. This laxity has inevitably led to the program being fleeced by them – to the tune of over a billion dollars. And that's just for a drug that doesn't even need to be in use.

Researchers from Johns Hopkins University report that they've set a new delivery distance record by using medical drones to safely deliver human blood samples 161 miles. The experiment in the Arizona desert ferried contents that "were viable for laboratory analysis after landing," with minimal related problems.

Ever wonder if your cabinet is full of expired medication? If so, what can you keep, and what should you toss?